The Alliance for Aging Research Supports Rep. Schrader's New Comparative Effectiveness Research Legislation
Washington, D.C. – On Tuesday, Rep. Kurt Schrader (D-OR), joined fellow New Democrat colleagues Rep. Ron Kind (D-WI) and Rep. Allyson Schwartz (D-PA), in introducing the Comparative Effectiveness Research (CER) Act of 2009 (H.R. 2502).
Daniel Perry, executive director of the Alliance for Aging Research, released the following statement in support of this new, patient-centered CER legislation: “Comparative effectiveness research has the potential to better inform healthcare decision making and transform the treatment of disease for all Americans. Because of their complex health needs, older Americans will be disproportionately affected by the widespread use of additional research on what interventions are more effective for treating age-associated disease and conditions.”
“We must ensure that future comparative effectiveness research is designed in a way that recognizes diversity among patients that could impact clinical outcomes. As Americans age at an unprecedented rate, it is important to consider all factors that could affect how care is delivered to older patients. H.R. 2502 establishes a comprehensive framework that allows patient input into the decision-making process on what CER priorities should be pursued and how best to conduct the research, while streamlining patient and provider access to this crucial information.”
Founded in 1986, the Alliance for Aging Research is a nonprofit, independent organization dedicated to improving the health and independence of aging Americans through public and private funding of medical research and geriatric education. The Alliance combines the interest of top scientists, public officials, business executives, and foundation leaders to promote a greater national investment in research and new technologies that will prepare our nation for the coming senior boom, and improve the quality of life for today’s older generation.